StockVS

Aflac Incorporated (AFL) Analyse boursière

Services Financiers

Aflac Incorporated

$116.82

$-1.04 (-0.88%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Actualités Récentes

Actualités fournies par des sources tierces. Ne constitue pas un conseil financier.

Analyse

Présentation de l'entreprise

Aflac Incorporated, through its subsidiaries, functions as a provider of supplemental health and life insurance products, operating primarily within the United States and Japan markets. The company is classified within the Financial Services sector and specifically within the Insurance - Life industry, which implies a business model focused on risk management and long-term liability management for policyholders. This entity employs a workforce of 12,716 individuals and holds a market capitalization of $59.22B, generating annual revenue of $17.16B in the trailing twelve months. These valuation and revenue figures indicate that the company operates at a significant scale, positioning it as a major player capable of influencing market dynamics within the insurance landscape through its substantial asset base and broad product distribution.

Santé financière

The financial performance of Aflac Incorporated is characterized by a trailing twelve-month revenue of $17.16B, net income of $3.65B, and EBITDA of $4.79B. The substantial gap between revenue and net income reveals a cost structure where operating expenses, including claims payments and administrative costs, consume approximately 78.8% of total revenue before reaching the bottom line. The company generates free cash flow of $5.18B, a figure that highlights its strong financial flexibility to fund operations, return capital to shareholders, or invest in technology without relying on external financing. Profitability is further dissected by three distinct margins: a gross margin of 46.6%, an operating margin of 33.6%, and a profit margin of 21.2%, where the decline from gross to profit margin illustrates the impact of underwriting and general administrative expenses on final earnings. On the balance sheet, the company holds $7.63B in cash against $12.59B in debt, resulting in a debt-to-equity ratio of 42.68, which suggests a leveraged balance sheet reliant on equity financing and retained earnings to cover obligations. Liquidity is assessed via a current ratio of 1.07, indicating that current assets slightly exceed current liabilities, though the buffer is relatively narrow for a financial institution. Return metrics show a Return on Equity of 13.1% and a Return on Assets of 2.5%, revealing that management is effective at generating returns for shareholders relative to equity invested, while the lower ROA reflects the capital-intensive nature of the insurance industry where assets significantly outweigh equity.

Évaluation de la valorisation

Valuation multiples for Aflac Incorporated include a trailing P/E ratio of 16.54 and a forward P/E of 14.55. The difference between these two metrics implies an expectation of earnings growth in the future, as the market is pricing in lower multiple requirements for the anticipated increase in profitability. The price-to-book ratio stands at 1.99, indicating that the market values the company at nearly double its book value, which suggests a premium assigned to its intangible assets and brand strength relative to tangible equity. Alternative valuation measures include a price-to-sales ratio of 3.45 and an EV/EBITDA of 13.22, which provide context on how much investors are paying per dollar of sales and operating earnings respectively. Regarding price momentum, the 52-week high is recorded at $119.32 and the low at $96.95; without the current specific price point provided in the facts, the relative position cannot be calculated, but the range defines the recent volatility envelope. The beta value is 0.65, which indicates that the stock price is less volatile than the broader market, suggesting lower sensitivity to general market swings compared to large-cap peers.

Growth & Income

Recent growth metrics show a revenue growth year-over-year of -9.9% and an earnings growth year-over-year of -22.9%. The fact that earnings growth is declining at a faster rate than revenue indicates a period of margin compression or significant one-time charges affecting the bottom line more severely than top-line sales. As a dividend payer, the company offers a dividend yield of 2.2% with a payout ratio of 34.0%. This payout ratio suggests that the dividend is sustainable given the company's earnings, as only a fraction of net income is distributed to shareholders, leaving ample room for retention. The earnings decline implies that the payout ratio may fluctuate if profitability does not stabilize, but the current level remains conservative relative to total earnings. Overall, the growth and income profile reflects a company currently navigating a contraction phase with a focus on maintaining dividend coverage while managing declining operational momentum.

Comparaison avec les pairs

Aflac Incorporated (AFL) opère dans le secteur Assurance - Vie. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
Aflac Incorporated AFL $59.46B 13.3
Manulife Financial Corporation MFC.TO $88.82B 15.3
Great-West Lifeco Inc. GWO.TO $71.39B 17.1
Manulife Financial Corporation MFC $64.39B 15.3

Le ratio P/E moyen du secteur Assurance - Vie est de 18.3x. Aflac Incorporated se négocie à un P/E de 13.3.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de Aflac Incorporated

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

La description de l'entreprise est affichée en anglais.

Visiter le site →

Statistiques Clés

Capitalisation
$59.46B
Ratio P/E
13.35
Plus Haut 52 Sem.
$119.81
Plus Bas 52 Sem.
$96.95
Volume Moyen
2.29M
Bêta
0.62
Rendement Dividende
2.09%

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NYSE
Pays
United States
Employés
12,716